We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Forms for members of the public to provide written evidence on young people’s drug use and naloxone provision.
A letter from the Minister of State for Fire and Policing to the ACMD, in response to the recommendation to Schedule Epidyolex.
First published during the 2019 to 2022 Johnson Conservative government
Letter from the ACMD Barriers to Research working group to collect written evidence from researchers about barriers to legitimate research with controlled drugs.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary advising on COVID-19 emergency measures to enable the supply of controlled drugs.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Secretary in response to the 6 January letter on GHB and GBL.
Letter to the Home Office regarding the appropriate Schedule for the cannabis-based product for medicinal use, Epidyolex, under the Misuse of Drugs Regulations 2001.
This report advises government on the number and nature of known fentanyl analogues, risk factors, pharmacology, toxic effects and misuse and associated harms.
Letter to the Home Secretary from the Chair of the Advisory Council on the Misuse of Drugs, outlining our self-commissioned workstreams planned for 2020.
A framework for the assessment of the impact of rescheduling cannabis-based products for medicinal use (CBPMs).
Report to the Minister for Crime Prevention, which recommends a revised generic description of ‘third generation’ synthetic cannabinoids.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Home Office about the future use and purpose of Temporary Class Drug Orders (TCDOs).
The Home Secretary, Sajid Javid has today announced the reappointment of Dr Owen Bowden-Jones as the chair of the Advisory Council on the Misuse of Drugs.
First published during the 2016 to 2019 May Conservative government
Safe housing key to tackling homeless drug misuse, says ACMD.
The number of older opiate users in treatment in England has tripled in just 12 years, a report by the ACMD reveals today.
Prison services could reduce drug-related harms by avoiding releasing vulnerable prisoners on a Friday, the ACMD has today advised the Home Secretary.
Letter to the Home Office about the appropriate control mechanism for 2, 4-Dinitrophenol (DNP).
Interim advice to the Home Office regarding the legitimate use of controlled drugs in research and healthcare.
Seven new members of the Advisory Council for the Misuse of Drugs (ACMD) have been announced today.
Further advice about the prescribing of controlled drugs by therapeutic radiographers.
The Advisory Council on the Misuse of Drugs response to the consultation by NICE on the draft scope of their guidance on cannabis-based products for medicinal use.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).